Explore comprehensive CDMO services offered by BMI Korea, supporting end-to-end Drug Development and Manufacturing. BMI Korea enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: South Korea
Description: BMI Korea is a South Korea-based CDMO (Contract Development and Manufacturing Organization) founded in 2005, specializing in the development, clinical trial material production, and commercial manufacturing of biopharmaceuticals, vaccines, mRNA products, and medical devices. They operate GMP-certified facilities in Jeju and Osong, providing end-to-end services including sterile formulation (liquid/lyophilized vials, prefilled syringes) and process optimization.
